Literature DB >> 15247719

Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins.

Stephen J Freedland1, Martha K Terris, Joseph C Presti, Christopher L Amling, Christopher J Kane, Bruce Trock, William J Aronson.   

Abstract

PURPOSE: We have previously shown that men with a body mass index (BMI) greater than 35 kg/m2 had higher rates of positive surgical margins and significantly higher biochemical recurrence rates following radical prostatectomy (RP). To determine whether the higher prostate specific antigen (PSA) recurrence rates were due solely to the higher positive margin rate, we examined whether obesity was an independent predictor of biochemical failure among men with negative surgical margins.
MATERIALS AND METHODS: We examined data from 1,250 men treated with RP between 1988 and 2003 at 5 equal access medical centers, of whom 731 had pathologically organ confined disease and negative surgical margins. Multivariate Cox proportional hazards analysis was used to determine if BMI was a significant independent predictor of biochemical recurrence.
RESULTS: Mean BMI significantly increased over time (p = 0.010). Black men were significantly more likely to be obese than white or nonwhite-nonblack men. After controlling for all preoperative characteristics, body mass index was a significant predictor of biochemical failure with moderately and severely obese men (BMI 35 kg/m2 or greater) having greater than a 4-fold increased risk of PSA failure (p = 0.035). After controlling for the higher pathological Gleason grades among obese men, body mass index remained a significant predictor of biochemical failure with moderately and severely obese men (BMI 35 kg/m2 or greater) having nearly a 4-fold increased risk for PSA failure (p = 0.036).
CONCLUSIONS: BMI 35 kg/m2 or greater was associated with higher grade tumors and worse outcome following RP in a cohort of men with favorable pathological findings. Thus, surgical technique (margin status) cannot fully explain the worse outcomes among obese men, suggesting that obesity may be associated with a biologically more aggressive form of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15247719     DOI: 10.1097/01.ju.0000135302.58378.ae

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  27 in total

1.  Dietary energy balance modulates prostate cancer progression in Hi-Myc mice.

Authors:  Jorge Blando; Tricia Moore; Stephen Hursting; Guiyu Jiang; Achinto Saha; Linda Beltran; Jianjun Shen; John Repass; Sara Strom; John DiGiovanni
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-27

Review 2.  The use of prostate-specific antigen kinetics to stratify risk in prostate cancer.

Authors:  Joseph Presti
Journal:  Curr Urol Rep       Date:  2008-05       Impact factor: 3.092

Review 3.  Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis.

Authors:  Yin Cao; Jing Ma
Journal:  Cancer Prev Res (Phila)       Date:  2011-01-13

Review 4.  Management of prostate cancer in HIV-positive patients.

Authors:  Matthew S Wosnitzer; Franklin C Lowe
Journal:  Nat Rev Urol       Date:  2010-04-27       Impact factor: 14.432

5.  Body mass index adjusted prostate-specific antigen and its application for prostate cancer screening.

Authors:  Yuanyuan Liang; Donna P Ankerst; Michael Sanchez; Robin J Leach; Ian M Thompson
Journal:  Urology       Date:  2010-08-24       Impact factor: 2.649

Review 6.  Obesity and cancer: mechanistic insights from transdisciplinary studies.

Authors:  Emma H Allott; Stephen D Hursting
Journal:  Endocr Relat Cancer       Date:  2015-09-15       Impact factor: 5.678

7.  Body mass index as a classifier to predict biochemical recurrence after radical prostatectomy in patients with lower prostate-specific antigen levels.

Authors:  Keisuke Goto; Hirotaka Nagamatsu; Jun Teishima; Yuki Kohada; Shinsuke Fujii; Yoshimasa Kurimura; Koji Mita; Masanobu Shigeta; Satoshi Maruyama; Yoji Inoue; Mitsuru Nakahara; Akio Matsubara
Journal:  Mol Clin Oncol       Date:  2017-04-10

8.  Hypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy.

Authors:  R Asmar; J L Beebe-Dimmer; K Korgavkar; G R Keele; K A Cooney
Journal:  Prostate Cancer Prostatic Dis       Date:  2012-08-21       Impact factor: 5.554

9.  Association between biomarkers of obesity and risk of high-grade prostatic intraepithelial neoplasia and prostate cancer--evidence of effect modification by prostate size.

Authors:  Jay H Fowke; Saundra Motley; Qi Dai; Raoul Concepcion; Daniel A Barocas
Journal:  Cancer Lett       Date:  2012-10-16       Impact factor: 8.679

10.  Does diabetes mellitus modify the association between 17q12 risk variant and prostate cancer aggressiveness?

Authors:  Stacy Loeb; Brian T Helfand; Donghui Kan; William B Isaacs; William J Catalona
Journal:  BJU Int       Date:  2009-07-20       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.